Immunogenicity and safety of BNT162b2 COVID-19 vaccine in a chronic lymphocytic leukaemia patient

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalJournal of Cellular and Molecular Medicine
DOIs
Publication statusAccepted/In press - 2021

ASJC Scopus subject areas

  • Molecular Medicine
  • Cell Biology

Cite this